Novavax, Inc. (NVAX) has a consensus analyst rating of Buy, based on 23 analysts covering the stock. Of those, 17 recommend buying, 3 recommend holding, and 3 recommend selling.
The analyst consensus price target for NVAX is $14.50, representing a +72.8% upside from the current price of $8.39. Price targets range from a low of $11.00 to a high of $18.00.
